Correlation Between Purple Biotech and Aptevo Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Purple Biotech and Aptevo Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Purple Biotech and Aptevo Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Purple Biotech and Aptevo Therapeutics, you can compare the effects of market volatilities on Purple Biotech and Aptevo Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Purple Biotech with a short position of Aptevo Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Purple Biotech and Aptevo Therapeutics.

Diversification Opportunities for Purple Biotech and Aptevo Therapeutics

0.31
  Correlation Coefficient

Weak diversification

The 3 months correlation between Purple and Aptevo is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding Purple Biotech and Aptevo Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aptevo Therapeutics and Purple Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Purple Biotech are associated (or correlated) with Aptevo Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aptevo Therapeutics has no effect on the direction of Purple Biotech i.e., Purple Biotech and Aptevo Therapeutics go up and down completely randomly.

Pair Corralation between Purple Biotech and Aptevo Therapeutics

Given the investment horizon of 90 days Purple Biotech is expected to under-perform the Aptevo Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Purple Biotech is 1.78 times less risky than Aptevo Therapeutics. The stock trades about -0.14 of its potential returns per unit of risk. The Aptevo Therapeutics is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest  79.00  in Aptevo Therapeutics on August 31, 2024 and sell it today you would lose (50.50) from holding Aptevo Therapeutics or give up 63.92% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy99.21%
ValuesDaily Returns

Purple Biotech  vs.  Aptevo Therapeutics

 Performance 
       Timeline  
Purple Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Purple Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental drivers remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Aptevo Therapeutics 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Aptevo Therapeutics are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, Aptevo Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.

Purple Biotech and Aptevo Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Purple Biotech and Aptevo Therapeutics

The main advantage of trading using opposite Purple Biotech and Aptevo Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Purple Biotech position performs unexpectedly, Aptevo Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aptevo Therapeutics will offset losses from the drop in Aptevo Therapeutics' long position.
The idea behind Purple Biotech and Aptevo Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Other Complementary Tools

Content Syndication
Quickly integrate customizable finance content to your own investment portal
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum